PTPMT1 and breast carcinoma: SRSF1 exerts oncogenic roles in breast cancer partially by regulating the alternative splicing of PTPMT1, which could be a therapeutic target candidate in breast cancer and a prognostic factor in HR + breast cancer patients [34].